Cytosorbents Ownership | Who Owns Cytosorbents?

Overview Forecast RevenueFinancials Chart Transcripts

Cytosorbents Ownership Summary

Cytosorbents is owned by 30.59% institutional investors, 3.82% insiders, and 65.59% retail investors. Avenir is the largest institutional shareholder, holding 5.47% of CTSO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.39% of its assets in Cytosorbents shares.

CTSO Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cytosorbents	30.59%	3.82%	65.59%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Medical Device Stocks	50.87%	7.99%	41.14%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Avenir	2.97M	5.47%	$2.09M
Skylands capital	2.84M	5.24%	$2.00M
Granahan investment management	2.66M	4.91%	$1.87M
Vanguard group	1.95M	3.59%	$1.37M
Neuberger berman group	1.54M	2.83%	$1.08M
Sargent investment group	1.43M	2.64%	$1.01M
Cm management	850.00K	1.57%	$597.55K
Blackrock	655.80K	1.21%	$461.03K
Geode capital management	434.64K	0.80%	$305.62K
Cibc private wealth group	172.65K	0.32%	$174.38K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Cm management	850.00K	0.55%	$597.55K
Skylands capital	2.84M	0.28%	$2.00M
Sargent investment group	1.43M	0.21%	$1.01M
Avenir	2.97M	0.20%	$2.09M
Granahan investment management	2.66M	0.07%	$1.87M
Seelaus asset management	18.80K	0.01%	$13.22K
Key client fiduciary advisors	34.56K	0.01%	$24.29K
Texas capital bank wealth management services	23.17K	0.00%	$16.29K
Neuberger berman group	1.54M	0.00%	$1.08M
Chicago partners investment group	19.08K	0.00%	$22.61K

Top Buyers

Holder	Shares	% Assets	Change
Susquehanna group, llp	89.79K	-	73.59K
Sargent investment group	1.43M	0.21%	67.18K
Ep wealth advisors	28.00K	0.00%	28.00K
Cm management	850.00K	0.55%	25.00K
Tower research capital llc (trc)	21.70K	0.00%	13.68K

Top Sellers

Holder	Shares	% Assets	Change
Granahan investment management	2.66M	0.07%	-381.02K
Neuberger berman group	1.54M	0.00%	-376.05K
Avenir	2.97M	0.20%	-202.43K
Blackrock	655.80K	-	-66.63K
Skylands capital	2.84M	0.28%	-34.77K

New Positions

Holder	Shares	% Assets	Change	Value
Ep wealth advisors	28.00K	0.00%	28.00K	$19.68K
Citadel advisors	500.00	-	500.00	$352.00
Fmr	285.00	-	285.00	$200.00

Sold Out

Holder	Change
Qube research	-1.00
Lazard asset management	-1.09K
Bank of new york mellon	-3.64K
Redwood wealth management group	-8.20K
Regal investment advisors	-11.51K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	49	4.26%	16,601,658	-5.30%	30	1.99%	11	-21.43%	17	13.33%
Mar 31, 2024	47	-7.84%	17,531,124	-2.28%	39	2.40%	14	-30.00%	15	7.14%
Dec 31, 2023	51	-5.56%	17,940,758	18.13%	40	3.40%	20	11.11%	14	-12.50%
Sep 30, 2023	54	-8.47%	15,187,943	0.02%	34	2.85%	18	-33.33%	16	45.45%
Jun 30, 2023	59	-4.84%	15,184,349	0.12%	34	2.88%	27	22.73%	11	-38.89%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.30M	2.39%	-
M&G (ACS) Granahan US Sm Cp Gr GBPZ1AAcc	763.50K	1.40%	-101.78K
Neuberger Berman Intrinsic Value I	726.14K	1.33%	-
Vanguard Institutional Extnd Mkt Idx Tr	568.23K	1.04%	-
JNL Multi-Manager Small Cap Growth A	539.48K	0.99%	-280.72K
Victory Small Cap Stock	338.89K	0.62%	-62.53K
Granahan Inv Mgt Sm-Cap Core Gr	338.36K	0.62%	-59.93K
Fidelity Extended Market Index	265.52K	0.49%	5.68K
Granahan Small Cap Select	155.01K	0.28%	-59.93K
Neuberger Berman Small Cap Intrinsic Val	128.91K	0.24%	-1.91K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 13, 2023	Sobel Alan D.	-	Buy	$15.79K
Dec 13, 2023	Sobel Alan D.	-	Buy	$30.00K
Dec 13, 2023	Deliargyris Efthymios	Chief Medical Officer	Buy	$30.00K
Dec 13, 2023	Deliargyris Efthymios	Chief Medical Officer	Buy	$15.79K
Dec 13, 2023	Capponi Vincent	President & COO	Buy	$25.00K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	16	-
2023 Q3	3	-

CTSO Ownership FAQ

Who Owns Cytosorbents?

Cytosorbents shareholders are primarily institutional investors at 30.59%, followed by 3.82% insiders and 65.59% retail investors. The average institutional ownership in Cytosorbents's industry, Medical Device Stocks, is 50.87%, which Cytosorbents falls below.

Who owns the most shares of Cytosorbents?

Cytosorbents’s largest shareholders are Avenir (2.97M shares, 5.47%), Skylands capital (2.84M shares, 5.24%), and Granahan investment management (2.66M shares, 4.91%). Together, they hold 15.62% of Cytosorbents’s total shares outstanding.

Does Blackrock own Cytosorbents?

Yes, BlackRock owns 1.21% of Cytosorbents, totaling 655.8K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 461.03K$. In the last quarter, BlackRock decreased its holdings by -66.63K shares, a -9.22% change.

Who is Cytosorbents’s biggest shareholder by percentage of total assets invested?

Cm management is Cytosorbents’s biggest shareholder by percentage of total assets invested, with 0.55% of its assets in 850K Cytosorbents shares, valued at 597.55K$.

Who is the top mutual fund holder of Cytosorbents shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cytosorbents shares, with 2.39% of its total shares outstanding invested in 1.3M Cytosorbents shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools